![Jay Venkatesan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 774 394 $ in data 30/09/2026
Dr. Jay R.
Venkatesan is an Independent Director at Serina Therapeutics, Inc., an Independent Director at Elicio Therapeutics, Inc., a Managing Partner at Alpine Bioventures, GP, LLC, a Managing Member at Ayer Capital Partners Master Fund LP and a President & Treasurer at Varro Technologies, Inc. He is on the Board of Directors at Serina Therapeutics, Inc., Elicio Therapeutics, Inc., Zylem Biosciences, Inc., Elicio Therapeutics, Inc. (United States) and Eurofins Transplant Genomics LLC.
Dr. Venkatesan was previously employed as a Chairman, President & Chief Executive Officer by Angion Biomedica Corp., an Independent Director by Alpine Immune Sciences, Inc., a President & Director by Alpine Immune Sciences, Inc. /Old/, a Chief Executive Officer by Alpine Biosciences, Inc., a Managing Partner by Alpine Bioventures LP, an Executive Vice President & General Manager by CASCADIAN THERAPEUTICS INC, an Independent Director by Exicure, Inc., an Independent Director by Iovance Biotherapeutics, Inc., a Founder & Managing Partner by Ayer Capital Management LP, a Co-Founder by Tangerine Technologies, Inc., a Consultant by McKinsey & Co., Inc., a Managing Member by ACM Capital Partners LLC, and a Principal by Patricof & Co. Ventures, Inc. He also served on the board at Cell Biotherapy, Inc., Exicure Operating Co., Targanta Therapeutics Corp., Brookside Capital LP, Brookside Mezzanine Partners Management LLC, REVA Medical, Inc. and Tivorsan Pharmaceuticals, Inc. He received his undergraduate degree from Williams College, an MBA from The Wharton School of the University of Pennsylvania and a doctorate degree from the University of Pennsylvania Medical Center.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
0,91% | 17/06/2026 | 232.294 ( 0,91% ) | 464 588 $ | 30/09/2026 |
| 17/09/2026 | 170.223 ( 0,65% ) | 309 806 $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ELICIO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/06/2023 |
Zylem Biosciences, Inc.
 Zylem Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company developing targeted medicines | Fondatore | 01/01/2018 |
Elicio Therapeutics, Inc. (United States)
 Elicio Therapeutics, Inc. (United States) BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel immunotherapies for treatment of cancer and other diseases | Direttore/Membro del Consiglio | - |
Alpine Bioventures, GP, LLC
 Alpine Bioventures, GP, LLC Investment ManagersFinance Alpine Bioventures is an active manager which invests in companies located in the United States. It targets companies operating in the fields of health technology and health services. It provides financing for seed and early stage capital requirements. | Investitore di Private Equity | 01/07/2015 |
Transplant Genomics, Inc.
 Transplant Genomics, Inc. BiotechnologyHealth Technology Operates as a molecular diagnostics company which focuses on kidney transplant recipients | Direttore/Membro del Consiglio | - |
Ayer Capital Partners Master Fund LP
 Ayer Capital Partners Master Fund LP Investment Trusts/Mutual FundsMiscellaneous Acts as Hedge Fund | Corporate Officer/Principal | - |
Varro Technologies, Inc.
 Varro Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops distributed knowledge management applications for the life-science industry | Fondatore | - |
| Società | Posizione | Fine |
|---|---|---|
| ANGN BIOM | Amministratore Delegato | 01/01/2023 |
Cell Biotherapy, Inc.
 Cell Biotherapy, Inc. BiotechnologyHealth Technology Engages in development of bio therapeutics | Direttore/Membro del Consiglio | 01/01/2023 |
| ░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 30 |
|---|---|
Bain Capital Public Equity LP
 Bain Capital Public Equity LP Investment ManagersFinance Bain Capital Public Equity employs long/short equity strategies that combine rigorous bottom-up, fundamental research with analytical portfolio construction to identify and capitalize on opportunities across the global equity markets. The firm seeks to achieve isolate alpha and generate attractive returns over a full market and industry cycle with low correlation to the equity markets. Their investment advisory activity focuses on advising the Public Equity Funds on investments in securities of publicly traded companies that offer opportunities to realize substantial long-term appreciation. Bain Capital Public Equity typically makes investments in securities at prices it believes to be below their intrinsic value based on a company’s normalized cash flow, growth potential and/or asset value. | Finance |
Targanta Therapeutics Corp.
 Targanta Therapeutics Corp. BiotechnologyHealth Technology Discovers and develops novel antibacterial pro drugs | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
ACM Capital Partners LLC
 ACM Capital Partners LLC Investment ManagersFinance ACM Capital Partners LLC is an active manager. | Finance |
Elicio Therapeutics, Inc. (United States)
Elicio Therapeutics, Inc. (United States) BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel immunotherapies for treatment of cancer and other diseases | Health Technology |
Transplant Genomics, Inc.
Transplant Genomics, Inc. BiotechnologyHealth Technology Operates as a molecular diagnostics company which focuses on kidney transplant recipients | Health Technology |
Alpine Immune Sciences, Inc. /Old/
 Alpine Immune Sciences, Inc. /Old/ BiotechnologyHealth Technology Operates as a biotechnology company which develops cancer immunotherapy systems | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Williams College
 Williams College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
REVA Medical, Inc.
 REVA Medical, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells implantable bio resorbable medical devices | Health Technology |
Brookside Mezzanine Partners Management LLC
 Brookside Mezzanine Partners Management LLC Investment ManagersFinance Brookside Capital Partners invests in lower middle-market companies located in the United States with revenues of more than USD 15 million and an EBITDA of more than USD 4 million. The firm focuses on business services, consumer, distribution, healthcare, transportation & logistics and manufacturing sectors. It provides financing in the form of debt and minority equity for strategic acquisitions, buyouts, leveraged recapitalizations, dividend payments and growth capital requirements with an investment size of USD 5 - 30 million. | Finance |
Patricof & Co. Ventures, Inc.
 Patricof & Co. Ventures, Inc. Investment ManagersFinance Acts as an alternative investment manager | Finance |
Varro Technologies, Inc.
Varro Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops distributed knowledge management applications for the life-science industry | Commercial Services |
Tangerine Technologies, Inc.
 Tangerine Technologies, Inc. Packaged SoftwareTechnology Services Provides software development and business process outsourcing solutions | Technology Services |
Ayer Capital Management LP
 Ayer Capital Management LP Investment ManagersFinance Ayer Capital Management manages a global healthcare long/short equity hedge fund. The firm invests across all market-caps and maintains a very high turnover rate | Finance |
Ayer Capital Partners Master Fund LP
Ayer Capital Partners Master Fund LP Investment Trusts/Mutual FundsMiscellaneous Acts as Hedge Fund | Miscellaneous |
Iovance Biotherapeutics, Inc.
 Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
Exicure Operating Co.
 Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Develops immunomodulatory and gene regulating drugs | Health Technology |
Tivorsan Pharmaceuticals, Inc.
 Tivorsan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics for the treatment of neuromuscular disorders | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Angion Biomedica Corp.
 Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products | Health Technology |
Alpine Biosciences, Inc.
 Alpine Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development of protocells for treatment of rare diseases and cancer | Commercial Services |
University of Pennsylvania Medical Center
 University of Pennsylvania Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alpine Bioventures, GP, LLC
Alpine Bioventures, GP, LLC Investment ManagersFinance Alpine Bioventures is an active manager which invests in companies located in the United States. It targets companies operating in the fields of health technology and health services. It provides financing for seed and early stage capital requirements. | Finance |
Alpine Bioventures LP
 Alpine Bioventures LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Alpine Immune Sciences, Inc.
 Alpine Immune Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as an bio pharmaceutical company that develops immunotherapies for autoimmune and inflammatory diseases | Health Technology |
Exicure, Inc.
 Exicure, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops nucleic acid therapies against to neurological disorders and hair loss | Health Technology |
Cell Biotherapy, Inc.
Cell Biotherapy, Inc. BiotechnologyHealth Technology Engages in development of bio therapeutics | Health Technology |
Zylem Biosciences, Inc.
Zylem Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company developing targeted medicines | Health Technology |
Elicio Therapeutics, Inc.
 Elicio Therapeutics, Inc. BiotechnologyHealth Technology Develops cancer immunotherapies | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
